ADAR1 Capital Management »

Disc Medicine shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $56k 896 62.26

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Disc Medicine

Atlas Venture Life Science Advisors
BlackRock
Bain Capital Life Sciences Investors
OrbiMed Advisors
Frazier Life Sciences Management
Paradigm Biocapital Advisors
BlackRock
T. Rowe Price Associates
Vanguard Group
Deerfield Management Company
Logos Global Management
Point72 Asset Management
State Street Corporation
Saturn V Capital Management
TCG Crossover Management

View all funds holding Disc Medicine